Long-Term Outcomes and Conditional Recurrence-Free Survival in Stage II Colon Cancer: The Impact of Surveillance and Recurrence Detection Strategies
Journal of Clinical Medicine · 24.06.2026 · 15 (13) · 4901
DOI: 10.3390/jcm15134901 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Clinical Medicine, online erschienen am 24.06.2026. Verfasst von Mustafa Alperen Tunç und 17 weiteren Autor:innen. Beteiligte Einrichtung: Division of Medical Oncology, Department of Internal Medicine, School of Medicine, Marmara University, Istanbul 34854, Türkiye. Die Arbeit nennt 23 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Adjuvant therapy decisions for T3N0 stage II colon cancer remain controversial. This study evaluates long-term outcomes, recurrence patterns, and conditional relapse-free survival (RFS) in pathologic T3N0 colon cancer.
Methods
This retrospective study included 306 patients undergoing curative resection for T3N0 colonic adenocarcinoma (1995–2020). Early recurrence was defined as recurrence or death within 3 years after surgery. Survival was estimated via Kaplan–Meier. Cox regression, adjusted for treatment eras, evaluated survival factors. Inverse Probability of Treatment Weighting (IPTW) minimized selection bias. Conditional RFS utilized a 5-year landmark analysis.
Results
Over a 133-month median follow-up, 72 patients (23.5%) recurred. Most recurrences (81.9%) occurred within 3 years; only 9.7% after 5 years. Five- and 10-year OS rates were 80.9% and 70.4%. Inadequate lymph node dissection (
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Medical Oncology, Department of Internal Medicine, School of Medicine, Marmara University, Istanbul 34854, Türkiye.
- Department of Medical Oncology, VM Medical Park Maltepe Hospital, Istanbul 34846, Türkiye.
- Department of Medical Oncology, Haydarpasa Numune Training and Research Hospital, Istanbul 34668, Türkiye.
- Department of General Surgery, Haydarpasa Numune Training and Research Hospital, Istanbul 34668, Türkiye.
ORCID-Profile: Mustafa Alperen Tunç, Ali Kaan Güren, Fırat Akagündüz, Erkam Kocaaslan, Ahmet Demirel, Yeşim Ağyol, Nargiz Majidova, Nadiye Sever, Selver Işık, Abdussamed Çelebi, İbrahim Vedat Bayoğlu, Murat Sarı
Zitieren
APA
Tunç, M. A., Güren, A. K., Paçacı, B., Akagündüz, F., Kocaaslan, E., Demirel, A., Ağyol, Y., Erel, P., Majidova, N., Sever, N., Tayyar Tunç, N., Demircan, N. C., Işık, S., Çelebi, A., Çoban, E., Köstek, O., Bayoğlu, İ. V., & Sarı, M. (2026). Long-Term Outcomes and Conditional Recurrence-Free Survival in Stage II Colon Cancer: The Impact of Surveillance and Recurrence Detection Strategies. Journal of Clinical Medicine, 15(13), 4901. https://doi.org/10.3390/jcm15134901
Vancouver
Tunç MA, Güren AK, Paçacı B, Akagündüz F, Kocaaslan E, Demirel A, et al. Long-Term Outcomes and Conditional Recurrence-Free Survival in Stage II Colon Cancer: The Impact of Surveillance and Recurrence Detection Strategies. Journal of Clinical Medicine. 2026;15(13):4901. doi:10.3390/jcm15134901
BibTeX
@article{Tun2026,
author = {Tunç, Mustafa Alperen and Güren, Ali Kaan and Paçacı, Burak and Akagündüz, Fırat and Kocaaslan, Erkam and Demirel, Ahmet and Ağyol, Yeşim and Erel, Pınar and Majidova, Nargiz and Sever, Nadiye and Tayyar Tunç, Naz and Demircan, Nazım Can and Işık, Selver and Çelebi, Abdussamed and Çoban, Ezgi and Köstek, Osman and Bayoğlu, İbrahim Vedat and Sarı, Murat},
title = {Long-Term Outcomes and Conditional Recurrence-Free Survival in Stage II Colon Cancer: The Impact of Surveillance and Recurrence Detection Strategies},
journal = {Journal of Clinical Medicine},
year = {2026},
volume = {15},
number = {13},
pages = {4901},
doi = {10.3390/jcm15134901}
}
EUVIMED